Skip to main content

Table 1 Baseline characteristics of all patients with COVID-19

From: Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score–matching analysis

 

Survivor(n = 176)

Non-survivor(n = 50)

P-value

Males (%)

82 (46.60%)

31 (62%)

0.077

Age (years)

49.93 (15.35)

67.82 (15.73)

< 0.001

Onset time (day)

7.16 (3.86)

6.54 (3.71)

0.619

Hypertension (%)

47 (26.70%)

37 (74%)

< 0.001

T2DM (%)

28 (15.91%)

17 (34%)

0.008

CHD (%)

6 (3.41%)

7 (14%)

0.010

COPD (%)

3 (1.70%)

3 (6.00%)

0.124

WBC (109)

5.15 (3.71–6.44)

5.73 (4.18–7.95)

0.078

N (109)

3.34 (2.34–4.76)

4.32 (2.97–7.05)

0.002

L (109)

1.10 (0.75–1.52)

0.66 (0.46–0.92)

< 0.001

N/L

2.98 (1.70–5.51)

6.18 (3.58–12.78)

< 0.001

ALT (U/L)

19.70 (13.60–33.65)

21.05 (14.33–29.48)

0.819

AST (U/L)

21.35 (17.20–32.95)

31.50 (22.40–44.33)

0.001

ALB (g/L)

39.24 (5.25)

35.55 (4.30)

< 0.001

sCr (μmol/L)

64.90 (52.20–75.93)

76.00 (58.00–109.20)

0.003

BUN (mmol/L)

3.97 (3.13–5.25)

6.60 (4.60–10.58)

< 0.001

CRP (mg/dL)

1.52 (0.28–5.03)

6.10 (3.53–8.84)

< 0.001

D-dimer (μg/mL)

0.56 (0.28–1.28)

6.21 (1.27–19.73)

< 0.001

  1. Abbreviations: Onset time, time from onset to admission (days); T2DM Type 2 diabetes mellitus; CHD Coronary heart disease; COPD Chronic obstructive pulmonary disease; WBC White blood cells; L Lymphocyte count; N Neutrophil count; N/L Ratio of neutrophils to lymphocytes; ALT alanine transaminase; AST Aspartate aminotransferase; ALB Serum albumin; sCr Serum creatinine; BUN Blood urea nitrogen; CRP C-reactive protein